Qianhai Health Foresees Return to Profit in 2024

Like
Comment
Favorite

Qianhai Health Foresees Return to Profit in 2024

MT Newswires Live03-06

Qianhai Health (HKG:0911) forecasts a return to net profit of about HK$1.3 million in 2024 from a loss of HK$52.7 million in 2023, according to a Thursday filing with the Hong Kong bourse.

The upbeat forecast is attributable to a return to a gross profit of HK$29.7 million from a gross loss a year earlier and a one-off gain of HK$51.9 million from the sale of subsidiaries, among others, the filing said.

The healthcare products distributor plans to release full-year results in March.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

抱歉，当前请求异常(-1)

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2517155062?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-06 19:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2517155062","market":"sh","top_or_hot":-1,"title":"Qianhai Health Foresees Return to Profit in 2024","media":"MT Newswires Live","content":"<html><body><p> Qianhai Health (HKG:0911) forecasts a return to net profit of about HK$1.3 million in 2024 from a loss of HK$52.7 million in 2023, according to a Thursday filing with the Hong Kong bourse.</p><p>The upbeat forecast is attributable to a return to a gross profit of HK$29.7 million from a gross loss a year earlier and a one-off gain of HK$51.9 million from the sale of subsidiaries, among others, the filing said.</p><p>The healthcare products distributor plans to release full-year results in March.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qianhai Health Foresees Return to Profit in 2024</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQianhai Health Foresees Return to Profit in 2024\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-03-06 19:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Qianhai Health (HKG:0911) forecasts a return to net profit of about HK$1.3 million in 2024 from a loss of HK$52.7 million in 2023, according to a Thursday filing with the Hong Kong bourse.</p><p>The upbeat forecast is attributable to a return to a gross profit of HK$29.7 million from a gross loss a year earlier and a one-off gain of HK$51.9 million from the sale of subsidiaries, among others, the filing said.</p><p>The healthcare products distributor plans to release full-year results in March.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1162","symbol_name":"技术产品经销商","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2517155062","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2517155062","pubTimestamp":1741261799,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Qianhai Health  forecasts a return to net profit of about HK$1.3 million in 2024 from a loss of HK$52.7 million in 2023, according to a Thursday filing with the Hong Kong bourse.The upbeat forecast is attributable to a return to a gross profit of HK$29.7 million from a gross loss a year earlier and a one-off gain of HK$51.9 million from the sale of subsidiaries, among others, the filing said.The healthcare products distributor plans to release full-year results in March.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1162":"技术产品经销商","BK1181":"经销商","00911":"前海健康"},"translate_title":"前海健康预计2024年恢复盈利","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00911":0.9},"content_text":"Qianhai Health (HKG:0911) forecasts a return to net profit of about HK$1.3 million in 2024 from a loss of HK$52.7 million in 2023, according to a Thursday filing with the Hong Kong bourse.The upbeat forecast is attributable to a return to a gross profit of HK$29.7 million from a gross loss a year earlier and a one-off gain of HK$51.9 million from the sale of subsidiaries, among others, the filing said.The healthcare products distributor plans to release full-year results in March.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}